Paul Sekhri

Paul Sekhri is an accomplished executive in the biotechnology and pharmaceutical sectors, serving as Chairman, President, and CEO of vTv Therapeutics, Inc. since August 2022. Sekhri holds multiple board positions, including Board Member for AdhereTech, ORYN Therapeutics, Spring Discovery, and Veeva Systems, along with Chairmanships at Longboard Pharmaceuticals and Compugen Ltd. Notably, Sekhri's leadership was instrumental at eGenesis, Inc., where groundbreaking advancements in xenotransplantation were made under their guidance as President and CEO until July 2024. Additional experience includes serving as Board Director at Ipsen and Chairman of the Board at Pharming Group N.V. Educational achievements include foundational studies at the University of Maryland School of Medicine and a Bachelor of Science degree in Zoology from the University of Maryland.